Xiawei Wei
- Immunology top 0.5%
- Immune cells in cancer 25
- Immunotherapy and Immune Responses 23
- Oncology top 0.5%
- Cancer Research top 1%
- Molecular Biology top 1%
- RNA Interference and Gene Delivery 23
- Epigenetics and DNA Methylation 14
- Advanced biosensing and bioanalysis techniques 11
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 12
-
- SARS-CoV-2 and COVID-19 Research 26
- COVID-19 Clinical Research Studies 14
- Co-authors
- Yuquan WeiXuelei MaWeiqi HongManni WangYong PengJing YangJi NieTianxia Lan
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Signal Transduction and Targeted Therapy (9 papers)Journal of Hematology & Oncology (8 papers)Cell Proliferation (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiawei Wei
185 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Immunology 3.1k
- Oncology 2.8k
- Cancer Research 1.5k
- Molecular Biology 5.9k
- Biomaterials 922
Countries citing papers authored by Xiawei Wei
This map shows the geographic impact of Xiawei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiawei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiawei Wei more than expected).
Fields of papers citing papers by Xiawei Wei
This network shows the impact of papers produced by Xiawei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiawei Wei. The network helps show where Xiawei Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiawei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 38 | |
| 7 | 2023 | 30 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 21 | |
| 10 | 2023 | 20 | |
| 11 | 2022 | 39 | |
| 12 | 2022 | 31 | |
| 13 | 2021 | 30 | |
| 14 | 2021 | 47 | |
| 15 | 2020 | 256 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 69 | |
| 18 | 2019 | 52 | |
| 19 | 2019 | 21 | |
| 20 | 2018 | 4 |
About Xiawei Wei
Xiawei Wei is a scholar working on Immunology, Infectious Diseases and Molecular Medicine, having authored 190 papers that have together received 12.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), Immune cells in cancer (25 papers), RNA Interference and Gene Delivery (23 papers), Immunotherapy and Immune Responses (23 papers), COVID-19 Clinical Research Studies (14 papers), Epigenetics and DNA Methylation (14 papers), Nanoparticle-Based Drug Delivery (12 papers) and Advanced biosensing and bioanalysis techniques (11 papers). The work is most often cited by research in Immunology (3.1k citations), Oncology (2.8k citations) and Cancer Research (1.5k citations). Xiawei Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuquan Wei, Xuelei Ma, Weiqi Hong, Manni Wang, Yong Peng, Jing Yang, Ji Nie, Tianxia Lan, Yuan Cheng and Zhiyong Qian. Their work appears in journals such as Signal Transduction and Targeted Therapy, Journal of Hematology & Oncology, Cell Proliferation, Scientific Reports and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.